Category: Healthcare

Roquette Pharma to Showcase its Comprehensive Range of Enabling Technologies at

Published: 15 September 2008
Written by Newsprovider
Roquette Pharma to Showcase its Comprehensive Range of Enabling Technologies at CPhI 2008 (September 15th 2008) Roquette Pharma, a longstanding supplier of high-quality raw materials and excipients for pharmaceutical and cosmetic applications, will be showcasing a selection of its key product ranges at CPhI Worldwide, Messe Frankfurt, Germany, September 30 – October 2 2008, stand 60D05. Roquette develops ingredients and excipients from natural harvests such as wheat, maize, pea and potatoes. Roquette offers a comprehensive product portfolio, ranging from starches and sugars to speciality products including polyols and cyclodextrins.
 New on Roquette’s stand at CPhI will be ReadiLYCOATTM. Roquette recently has announced a European strategic partnership with Biogrund for the development of ReadiLYCOAT™, a new ready-to-use film coating platform for pharmaceutical and nutraceutical applications. Utilising Roquette’s new starch-based film coating polymer LYCOAT®, ReadiLYCOAT™ has opened the way for a series of remarkable advances in film coating. Most notably, ReadiLYCOATTM offers a dramatic reduction in coating time and does not affect the dissolution and stability, regardless of the API. Roquette’s LYCOAT® is an aqueous film coating polymer which ensures low viscosity dispersions at a high solids content. Its excellent film integrity and adhesion qualities provide additional advantages. Among the product brands shown on stand 60D05 will be PEARLITOL®, Roquette’s mannitol range. With very low hygroscopicity and exceptional chemical stability, PEARLITOL® mannitol offers the ideal solution in excipients for stable formulations. In addition, PEARLITOL® offers grades for a wide range of applications from classical tablets and capsules to sachets. Also showcased on stand 60D05 will be Roquette’s KLEPTOSE®, a second generation range of modified betacyclodextrins. Together with different substituted betacyclodextrins, the KLEPTOSE® range caters for the specific needs of the pharmaceutical and cosmetic industry. The pioneering Roquette range offers several advantages including the possibility of increased solubilisation power while maintaining a high biological tolerance. For further information about Roquette’s pioneering range of enabling technologies please visit stand 60D05, CPhI 2008, Germany, September 30 – October 2. Alternatively, please e-mail This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.roquette-pharma.com